Oaktree Acquisition III Life Sciences EBITDA Margin 2025-2024 | OACC
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Oaktree Acquisition III Life Sciences (OACC) over the last 10 years. The current EBITDA margin for Oaktree Acquisition III Life Sciences as of September 30, 2024 is .
| Oaktree Acquisition III Life Sciences EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| Sector |
Industry |
Market Cap |
Revenue |
|
|
$0.224B |
$0.000B |
|
Oaktree Acquisition Corp. III Life Sciences is a blank check company. It formed for the purpose of entering into a combination with one or more businesses or entities. Oaktree Acquisition Corp. III is based in LOS ANGELES.
|
